Does the Efficacy of Semaglutide Treatment Differ between Low-Risk and High-Risk Subgroups of Patients with Type 2 Diabetes and Obesity Based on SCORE2, SCORE2-Diabetes, and ASCVD Calculations?

Martina Matovinović*, Andrej Belančić, Juraj Jug, Filip Mustač*, Maja Sirovica, Mihovil Santini, Anja Bošnjaković, Mario Lovrić, Martina Lovrić Benčić

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Does the Efficacy of Semaglutide Treatment Differ between Low-Risk and High-Risk Subgroups of Patients with Type 2 Diabetes and Obesity Based on SCORE2, SCORE2-Diabetes, and ASCVD Calculations?'. Together they form a unique fingerprint.